You are viewing the Novo Nordisk Virtual platform, provided to non-US health care professionals from around the world. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional.
This site is not country-specific and therefore may contain information which is not applicable to your country. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.
This site is not intended to provide medical advice and/or treatment guidance. Novo Nordisk accepts no liability for the accuracy, completeness or use of the information, and disclaims any liability to update the information contained on this site.
From May 12-15 2024, Venice, Italy, sets the stage for the 31st European Congress on Obesity (ECO2024). The ECO congress provides an opportunity to delve into the latest breakthroughs within the field of obesity science and weight management. The congress is a platform for engagement with peers from the global obesity community fostering discussions and exploration of the most recent advancements in obesity research and clinical practice. The ECO2024 congress is hosted by The European Association for the Study of Obesity (EASO). Established in 1986, EASO is a leading voice of obesity research and medical management of obesity in Europe.
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019. Update From the GBD 2019 Study. J Am Coll Cardiol. 2020 Dec.76(25)2982–3021. Doi: 10.1016/j.jacc.2020.11.010.
Halford JCG, et al. Misalignment among adolescents living with obesity, caregivers, and healthcare professionals: ACTION Teens global survey study. Pediatric Obesity.2022;17:e12957. Available at: https://onlinelibrary.wiley.com/doi/10.1111/ijpo.12957 Last accessed September 2023.